XML 28 R9.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statement of Cash Flows (Unaudited) - Williams - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
OPERATING ACTIVITIES:    
Net income (loss) $ 1,995 $ 1,829
Adjustments to reconcile to net cash provided (used) by operating activities:    
Depreciation, depletion, and amortization 1,754 1,654
Provision (benefit) for deferred income taxes 442 467
Equity (earnings) losses (449) (431)
Distributions from equity-method investees 600 580
Net unrealized (gain) loss from commodity derivative instruments (55) 210
Gain on disposition of equity-method investments (Note 3) 0 (149)
Gain on remeasurement of equity-method investments (Note 3) 0 (127)
Inventory write-downs 5 8
Amortization of stock-based awards 70 69
Cash provided (used) by changes in current assets and liabilities:    
Accounts receivable 384 367
Inventories (66) (6)
Other current assets and deferred charges (43) (16)
Accounts payable (359) (317)
Other current liabilities 95 (108)
Changes in current and noncurrent commodity derivative assets and liabilities 77 (74)
Other, including changes in noncurrent assets and liabilities (128) (200)
Net cash provided (used) by operating activities 4,322 3,756
FINANCING ACTIVITIES:    
Proceeds from (payments of) commercial paper – net (284) (723)
Proceeds from long-term debt 2,994 3,594
Payments of long-term debt (1,733) (2,286)
Payments for debt issuance costs (29) (31)
Proceeds from issuance of common stock 9 8
Common dividends paid (1,832) (1,737)
Dividends and distributions paid to noncontrolling interests (197) (178)
Contributions from noncontrolling interests 22 36
Other – net (60) (34)
Net cash provided (used) by financing activities (1,110) (1,351)
INVESTING ACTIVITIES:    
Capital expenditures (1) (2,938) (1,805)
Dispositions – net (80) (73)
Purchases of businesses, net of cash acquired (Note 3) (1) (1,995)
Proceeds from dispositions of equity-method investments (Note 3) 0 161
Purchases of and contributions to equity-method investments (192) (101)
Other – net 9 20
Net cash provided (used) by investing activities (3,202) (3,793)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total 10 (1,388)
Cash and cash equivalents at beginning of year 60 2,150
Cash and cash equivalents at end of period 70 762
Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]    
(1)  Increases to property, plant, and equipment (3,079) (1,840)
Changes in related accounts payable and accrued liabilities 141 35
Capital expenditures $ (2,938) $ (1,805)